Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Approved for marketing 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

CNS 11Genitourinary 2Gastrointestinal 2Breast 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Prostatic Neoplasms 2

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gadolinium × Genitourinary × Clear all
NCT04809584 2024-12-19

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Stanford University

Approved for marketing
Genitourinary

Prostatic Neoplasms

NCT01562223 2021-10-18

A6701QIBA

American College of Radiology Imaging Network

Phase NA Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡